METTL14-catalyzed m6A modification is markedly reduced in ovarian carcinoma tissues, and reinstatement of METTL14 expression may attenuate ovarian cancer cell proliferative capacity by repressing trophinin-associated protein (TROAP) levels [153]. Here, METTL14 is linked to ovarian carcinoma.